Welcome to the BioRegen REJUVENATION research hub, a curated entry point for laboratory scientists exploring the biology of aging, cellular senescence, and tissue regeneration. All information here is for laboratory and educational research only. No compound referenced is approved for human or veterinary use, and nothing here is medical advice. This hub organizes background context and links to help researchers locate reference materials and compounds for in vitro and preclinical study.
What the rejuvenation research area covers
Rejuvenation research is a broad scientific field examining how cells and tissues change with age and which biological pathways researchers study in models of aging. In published research, scientists investigate mechanisms such as cellular senescence, mitochondrial function, proteostasis, and the signaling factors that circulate in younger versus older organisms. The aim of this research area, as described in the academic literature, is to understand these processes at a mechanistic level. BioRegen does not make or endorse any therapeutic claims; this hub simply maps the landscape that researchers study.
Kinds of compounds studied here
The compounds catalogued under this research line are peptides and related molecules that appear in published aging and regeneration studies. Researchers have examined factors such as growth differentiation factor 11 (GDF11) and platelet-derived signaling factors as candidate “rejuvenation factors” in animal and cell models. Studies have also explored signaling proteins linked to longevity programs and to synaptic and immune changes in aged tissue. To browse the reference compounds organized under this area, use the catalog button below. Selection of a compound for a study should follow each researcher’s own protocol and institutional review.
Research stage and limitations
It is important to note that the science in this area is largely preclinical. Much of the published work involves cell cultures and animal models, and reviewers note that underlying mechanisms are often not fully established and that some findings remain controversial. None of the compounds discussed here is an approved drug, and none should be understood as a treatment. Researchers planning work in this space typically begin by reviewing the primary literature and defining handling, storage, and reconstitution procedures appropriate to their laboratory. For background on preparing lyophilized materials in a lab setting, see our guide to reconstituting peptides.
Finding the right reference material
If you are not sure where to start, the BioRegen Research Finder helps you locate compounds by research area, and the Research Guide provides additional educational background on handling and study design. These resources are intended to support informed, compliant laboratory work and to help researchers cross-reference the published literature before acquiring any material.
Join the BioRegen research list
Subscribe for new research hub updates and reference summaries. New subscribers can use code RESEARCH10 for 10% off a first order of laboratory reference materials.
Selected research references
- Ma Y, et al. Growth differentiation factor 11: a “rejuvenation factor” involved in regulation of age-related diseases? Aging (Albany NY), 2021. https://doi.org/10.18632/aging.202881
- Li L, Xie C. PF4 in rejuvenation therapy: Neuroprotection and cognitive enhancement. Biomolecules & Biomedicine, 2025. https://doi.org/10.17305/bb.2025.11960
Reference metadata sourced via PubMed.
All information on this page is provided strictly for laboratory and educational research purposes. No compound referenced is approved for human or veterinary use, no statement here should be interpreted as medical advice, and nothing here claims to diagnose, treat, cure, or prevent any disease. BioRegen does not make or endorse therapeutic claims.